Goldman Sachs Asset Management’s alternative investments & manager selection business (AIMS), has appointed Enfusion, a U.S.-based fintech focused on the investment management sector, to provide investment management technology solutions and middle- and back-office managed services. Enfusion created a customised solution via API so that AIMS can import data into the Enfusion platform in real-time, providing a holistic view of a fund for portfolio managers and the risk team. In 2012 GSAM sold its administration business to State Street for USD550m.
